Guangzhou Baiy reported CNY16.05B in Sales Revenues for its fiscal quarter ending in December of 2026.





Sales Change Date
Aspen Pharmacare ZAR 17.08B 4.32B Dec/2025
Cipla INR 74.04B 2.85B Sep/2026
Dr.Reddys Laboratories INR 86.98B 6.27B Sep/2026
Jiangsu Hengrui CNY 8.95B 320M Sep/2026
Kalbe Farma IDR 9.5T 305.24B Sep/2026
Richter Gedeon HUF 241.39B 21.19B Jun/2026
Sh Fosun Pharma CNY 10.07B 50M Dec/2026
Sh Pharmaceutical CNY 75.49B 3.5B Sep/2026
Sun Pharmaceuticals INR 161.99B 8.99B Sep/2026
Teva Pharmaceutical Industries USD 4.37B 8.3B Sep/2026